Cargando…
Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation
The reversibility of non-genotoxic phenotypic changes has been explored in order to develop novel preventive and therapeutic approaches for cancer. Quisinostat (JNJ-26481585), a novel second-generation histone deacetylase inhibitor (HDACi), has efficient therapeutic actions on non-small cell lung ca...
Autores principales: | Bao, Lianmin, Diao, Hua, Dong, Nian, Su, Xiaoqiong, Wang, Bingbin, Mo, Qiongya, Yu, Heguo, Wang, Xiangdong, Chen, Chengshui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099365/ https://www.ncbi.nlm.nih.gov/pubmed/27423454 http://dx.doi.org/10.1007/s10565-016-9347-8 |
Ejemplares similares
-
The Clinical Clues of Pulmonary Alveolar Proteinosis: A Report of 11 Cases and Literature Review
por: Mo, Qiongya, et al.
Publicado: (2016) -
Acetylation and Histone Deacetylase Inhibitors in Cancer
por: Kortenhorst, Madeleine S. Q., et al.
Publicado: (2006) -
Histone acetylation and the role of histone deacetylases in normal cyclic endometrium
por: Gujral, Palak, et al.
Publicado: (2020) -
Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?
por: Stintzing, Sebastian, et al.
Publicado: (2011) -
Histone Deacetylase Inhibitors Romidepsin and Vorinostat Promote Hepatitis B Virus Replication by Inducing Cell Cycle Arrest
por: Yang, Yang, et al.
Publicado: (2021)